Applied BioCode Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 43

Employees

  • Stock Symbol
  • 6598

Stock Symbol

  • Share Price
  • $0.71
  • (As of Tuesday Closing)

Applied BioCode General Information

Description

Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 12130 Mora Drive
  • Unit 2
  • Santa Fe Springs, CA 90670
  • United States
+1 (833)
Primary Industry
Discovery Tools (Healthcare)
Stock Exchange
TAI
Vertical(s)
Corporate Office
  • 12130 Mora Drive
  • Unit 2
  • Santa Fe Springs, CA 90670
  • United States
+1 (833)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Applied BioCode Stock Performance

As of 21-Jan-2025, Applied BioCode’s stock price is $0.71. Its current market cap is $72.7M with 103M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.71 $0.73 $0.56 - $1.00 $72.7M 103M 234K -$0.07

Applied BioCode Financials Summary

As of 30-Sep-2024, Applied BioCode has a trailing 12-month revenue of $12.1M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 58,621 46,794 55,275 103,308
Revenue 12,086 12,687 13,110 11,450
EBITDA (4,980) (3,934) (4,498) (4,096)
Net Income (6,211) (5,272) (6,205) (5,912)
Total Assets 39,462 32,323 39,522 36,801
Total Debt 733 1,121 1,601 2,122
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Applied BioCode Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Applied BioCode‘s full profile, request access.

Request a free trial

Applied BioCode Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Applied BioCode‘s full profile, request access.

Request a free trial

Applied BioCode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products
Discovery Tools (Healthcare)
Santa Fe Springs, CA
43 As of 2016

Berkeley, CA
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Applied BioCode Competitors (33)

One of Applied BioCode’s 33 competitors is Correlia Biosystems, a Venture Capital-Backed company based in Berkeley, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Correlia Biosystems Venture Capital-Backed Berkeley, CA
Luminex Corporate Backed or Acquired Austin, TX
NECi (Biotechnology) Accelerator/Incubator Backed Lake Linden, MI
CELL BIOLABS Corporation San Diego, CA
Standard BioTools Formerly VC-backed San Francisco, CA
You’re viewing 5 of 33 competitors. Get the full list »

Applied BioCode Patents

Applied BioCode Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240253055-A1 Integrated magnetic bead assay processing method and apparatus Pending 31-Jan-2023
US-20120088691-A1 Highly multiplexed real-time pcr using encoded microbeads Inactive 08-Oct-2010
US-20110007955-A1 Apparatus and method for barcoded magnetic beads analysis Inactive 08-Jul-2009
EP-2342561-A1 Biocompatible and photocurable polymers Active 08-Oct-2008
EP-2342561-A4 Biocompatible and photocurable polymers Active 08-Oct-2008 G01N33/545
To view Applied BioCode’s complete patent history, request access »

Applied BioCode Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Applied BioCode Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Applied BioCode‘s full profile, request access.

Request a free trial

Applied BioCode FAQs

  • When was Applied BioCode founded?

    Applied BioCode was founded in 2008.

  • Where is Applied BioCode headquartered?

    Applied BioCode is headquartered in Santa Fe Springs, CA.

  • What is the size of Applied BioCode?

    Applied BioCode has 43 total employees.

  • What industry is Applied BioCode in?

    Applied BioCode’s primary industry is Discovery Tools (Healthcare).

  • Is Applied BioCode a private or public company?

    Applied BioCode is a Public company.

  • What is Applied BioCode’s stock symbol?

    The ticker symbol for Applied BioCode is 6598.

  • What is the current stock price of Applied BioCode?

    As of 21-Jan-2025 the stock price of Applied BioCode is $0.71.

  • What is the current market cap of Applied BioCode?

    The current market capitalization of Applied BioCode is $72.7M.

  • What is Applied BioCode’s current revenue?

    The trailing twelve month revenue for Applied BioCode is $12.1M.

  • Who are Applied BioCode’s competitors?

    Correlia Biosystems, Luminex, NECi (Biotechnology), CELL BIOLABS, and Standard BioTools are some of the 33 competitors of Applied BioCode.

  • What is Applied BioCode’s annual earnings per share (EPS)?

    Applied BioCode’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »